BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 22821403)

  • 1. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
    Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
    Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.
    Janse M; Lamberts LE; Franke L; Raychaudhuri S; Ellinghaus E; Muri Boberg K; Melum E; Folseraas T; Schrumpf E; Bergquist A; Björnsson E; Fu J; Jan Westra H; Groen HJ; Fehrmann RS; Smolonska J; van den Berg LH; Ophoff RA; Porte RJ; Weismüller TJ; Wedemeyer J; Schramm C; Sterneck M; Günther R; Braun F; Vermeire S; Henckaerts L; Wijmenga C; Ponsioen CY; Schreiber S; Karlsen TH; Franke A; Weersma RK
    Hepatology; 2011 Jun; 53(6):1977-85. PubMed ID: 21425313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association analysis in primary sclerosing cholangitis.
    Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
    Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.
    Festen EA; Stokkers PC; van Diemen CC; van Bodegraven AA; Boezen HM; Crusius BJ; Hommes DW; van der Woude CJ; Balschun T; Verspaget HW; Schreiber S; de Jong DJ; Franke A; Dijkstra G; Wijmenga C; Weersma RK
    Am J Gastroenterol; 2010 Feb; 105(2):395-402. PubMed ID: 19861958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGR5 sequence variation in primary sclerosing cholangitis.
    Hov JR; Keitel V; Schrumpf E; Häussinger D; Karlsen TH
    Dig Dis; 2011; 29(1):78-84. PubMed ID: 21691110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
    Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
    BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
    Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
    Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
    Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
    Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
    Folseraas T; Melum E; Rausch P; Juran BD; Ellinghaus E; Shiryaev A; Laerdahl JK; Ellinghaus D; Schramm C; Weismüller TJ; Gotthardt DN; Hov JR; Clausen OP; Weersma RK; Janse M; Boberg KM; Björnsson E; Marschall HU; Cleynen I; Rosenstiel P; Holm K; Teufel A; Rust C; Gieger C; Wichmann HE; Bergquist A; Ryu E; Ponsioen CY; Runz H; Sterneck M; Vermeire S; Beuers U; Wijmenga C; Schrumpf E; Manns MP; Lazaridis KN; Schreiber S; Baines JF; Franke A; Karlsen TH
    J Hepatol; 2012 Aug; 57(2):366-75. PubMed ID: 22521342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array.
    Okamoto D; Kawai Y; Kakuta Y; Naito T; Torisu T; Hirano A; Umeno J; Fuyuno Y; Li D; Nakano T; Izumiyama Y; Ichikawa R; Hiramoto K; Moroi R; Kuroha M; Kanazawa Y; Shiga H; Tokunaga K; Nakamura M; Esaki M; Matsumoto T; McGovern DPB; Nagasaki M; Kinouchi Y; Masamune A
    Inflamm Bowel Dis; 2020 Jul; 26(8):1177-1187. PubMed ID: 32072174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.
    Ji SG; Juran BD; Mucha S; Folseraas T; Jostins L; Melum E; Kumasaka N; Atkinson EJ; Schlicht EM; Liu JZ; Shah T; Gutierrez-Achury J; Boberg KM; Bergquist A; Vermeire S; Eksteen B; Durie PR; Farkkila M; Müller T; Schramm C; Sterneck M; Weismüller TJ; Gotthardt DN; Ellinghaus D; Braun F; Teufel A; Laudes M; Lieb W; Jacobs G; Beuers U; Weersma RK; Wijmenga C; Marschall HU; Milkiewicz P; Pares A; Kontula K; Chazouillères O; Invernizzi P; Goode E; Spiess K; Moore C; Sambrook J; Ouwehand WH; Roberts DJ; Danesh J; Floreani A; Gulamhusein AF; Eaton JE; Schreiber S; Coltescu C; Bowlus CL; Luketic VA; Odin JA; Chopra KB; Kowdley KV; Chalasani N; Manns MP; Srivastava B; Mells G; Sandford RN; Alexander G; Gaffney DJ; Chapman RW; Hirschfield GM; de Andrade M; ; ; ; Rushbrook SM; Franke A; Karlsen TH; Lazaridis KN; Anderson CA
    Nat Genet; 2017 Feb; 49(2):269-273. PubMed ID: 27992413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.
    Bowlus CL; Karlsen TH; Broomé U; Thorsby E; Vatn M; Schrumpf E; Lie BA; Boberg KM
    J Hepatol; 2006 Nov; 45(5):704-10. PubMed ID: 16750586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis.
    Julià A; Domènech E; Chaparro M; García-Sánchez V; Gomollón F; Panés J; Mañosa M; Barreiro-De Acosta M; Gutiérrez A; Garcia-Planella E; Aguas M; Muñoz F; Esteve M; Mendoza JL; Vera M; Márquez L; Tortosa R; López-Lasanta M; Alonso A; Gelpí JL; García-Montero AC; Bertranpetit J; Absher D; Myers RM; Gisbert JP; Marsal S
    Hum Mol Genet; 2014 Dec; 23(25):6927-34. PubMed ID: 25082827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
    Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.
    Srivastava B; Mells GF; Cordell HJ; Muriithi A; Brown M; Ellinghaus E; Franke A; ; Karlsen TH; Sandford RN; Alexander GJ; Chapman RW; Rushbrook SM; Melum E
    Scand J Gastroenterol; 2012 Jul; 47(7):820-6. PubMed ID: 22554193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
    Okada Y; Yamazaki K; Umeno J; Takahashi A; Kumasaka N; Ashikawa K; Aoi T; Takazoe M; Matsui T; Hirano A; Matsumoto T; Kamatani N; Nakamura Y; Yamamoto K; Kubo M
    Gastroenterology; 2011 Sep; 141(3):864-871.e1-5. PubMed ID: 21699788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
    Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
    Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis.
    Umeno J; Asano K; Matsushita T; Matsumoto T; Kiyohara Y; Iida M; Nakamura Y; Kamatani N; Kubo M
    Inflamm Bowel Dis; 2011 Dec; 17(12):2407-15. PubMed ID: 21351207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.
    Park YE; Cheon JH; Park JJ; Kim YJ; Choi CH; Park Y; Park SJ; Kim TI; Kim WH
    Int J Colorectal Dis; 2018 Oct; 33(10):1497-1500. PubMed ID: 29987360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
    Juran BD; Atkinson EJ; Schlicht EM; Larson JJ; Ellinghaus D; Franke A; Lazaridis KN
    Liver Int; 2011 Jul; 31(6):785-91. PubMed ID: 21134112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.